Through integration of methylome data with the corresponding RNA-seq expression profiles (see WP 8) the interpretation of cancer associated changes in gene expression will be greatly enhanced. The aim is to identify potential prognostic and predictive markers and gain insight into the molecular pathomechanisms that might become the basis for development of effective therapies in the future.
People
 |
Dr. Bernhard Radlwimmer Group Leader E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. |